Follow The Filings

COCP

Earnings company data as of 4:47 AM ET 10/22

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by COCP's executives, directors and 10% owners in the last 12 months, from their Form 4s

All COCP insider trades
  • $300K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Phillip Et Al Frost MD Director
    Buy
    $9,816 10,000 shares at $0.9800 +0.5% to stake
    Traded Aug 5 Filed Aug 6
  2. Phillip Et Al Frost MD Director
    Buy
    $71K 75,000 shares at $0.9400 +3.9% to stake
    Traded Aug 3 Filed Aug 5
  3. Phillip Et Al Frost MD Director
    Buy
    $20K 20,000 shares at $1.00 +1.1% to stake
    Traded Feb 24 Filed Feb 25
  4. Phillip Et Al Frost MD Director
    Buy
    $47K 50,000 shares at $0.9500 +2.7% to stake
    Traded Feb 6 Filed Feb 9
  5. Phillip Et Al Frost MD Director
    Buy
    $47K 50,000 shares at $0.9500 +2.8% to stake
    Traded Dec 31, 2025 Filed Jan 2
  6. Phillip Et Al Frost MD Director
    Buy
    $19K 20,000 shares at $0.9700 +1.1% to stake
    Traded Dec 30, 2025 Filed Dec 31, 2025
  7. Phillip Et Al Frost MD Director
    Buy
    $63K 65,000 shares at $0.9700 +3.8% to stake
    Traded Dec 24–26 Filed Dec 29, 2025
  8. Phillip Et Al Frost MD Director
    Buy
    $3,975 4,000 shares at $0.9900 +0.2% to stake
    Traded Nov 26, 2025 Filed Nov 28, 2025
  9. Phillip Et Al Frost MD Director
    Buy
    $19K 20,000 shares at $0.9400 +1.2% to stake
    Traded Nov 25, 2025 Filed Nov 25, 2025

Also filed in the last 12 months, not counted as buying or selling: 4 stock grants.

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
8-K 7.01,9.01
8-K 5.02,9.01
8-K 7.01,9.01
10-Q
SCHEDULE 13D/A —
SCHEDULE 13D —
8-K 1.01,3.02,7.01,9.01
8-K 5.07
8-K 5.02,9.01
8-K 7.01,9.01
DEF 14A
DEFA14A
8-K 7.01,9.01
10-Q
8-K 7.01,9.01
8-K 7.01,9.01
8-K 2.02,9.01
10-K
8-K 5.02
8-K 7.01,9.01
8-K 7.01,9.01
8-K 5.02
8-K 7.01,9.01
8-K 7.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.